OMTH Insider Trading Activity and SEC Form 4 Filings
OMTH insider trading summary
No open-market insider purchases or sales of Omthera Pharmaceuticals, Inc. (OMTH) have been reported on SEC Form 4 in the past 12 months.
Latest OMTH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 16, 2013 | Peter J Barris | 10% Owner | Sell | $2K (196 @ $8.00) |
| Apr 16, 2013 | David M Mott | Director | Sell | $2K (196 @ $8.00) |
| Apr 16, 2013 | M James Barrett | 10% Owner | Sell | $2K (196 @ $8.00) |
| Apr 16, 2013 | Patrick J Kerins | 10% Owner | Sell | $2K (196 @ $8.00) |
| Apr 16, 2013 | David M Mott | Director | Buy | $5.0M (625,000 @ $8.00) |
| Apr 16, 2013 | M James Barrett | 10% Owner | Buy | $5.0M (625,000 @ $8.00) |
| Apr 16, 2013 | Scott D Sandell | 10% Owner | Sell | $2K (196 @ $8.00) |
| Apr 16, 2013 | Patrick J Kerins | 10% Owner | Buy | $5.0M (625,000 @ $8.00) |
| Apr 16, 2013 | Scott D Sandell | 10% Owner | Buy | $5.0M (625,000 @ $8.00) |
| Apr 16, 2013 | Peter J Barris | 10% Owner | Buy | $5.0M (625,000 @ $8.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.